In the present study population, patients with the AG 49 AA allele had a better RFS and OS, but this did not reach statistical significance.
← all excerpts
Evaluation of six CTLA-4 polymorphisms in high-risk melanoma patients receiving adjuvant interferon therapy in the He13A/98 multicenter trial.
1
—
—